Thomas Scientific Accelerates Investments in Molecular Diagnostics
The company’s new molecular diagnostics business unit is dedicated to serving the nation's independent testing and reference laboratories.
The company’s new molecular diagnostics business unit is dedicated to serving the nation's independent testing and reference laboratories.
The BARDA funding is for the validation and submission of the Simplexa Covid-19 Direct kit and the Simplexa Covid-19 & Flu A/B Direct kit for FDA 510(k) clearance.
COLA CEO Nancy Stratton offers a perspective on the impact covid-19 has had on clinical labs.
The covid-19 antibody test available on the Simoa HD-X Analyzer detects and quantitates IgG antibodies to SARS-CoV-2 in serum or EDTA plasma.
Read MoreThe FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests.
Read MoreThe self-administered, noninvasive saliva kits are FDA authorized for use by both individuals with and without symptoms of covid-19.
Read MoreSDNA-1000 Saliva Collection Device will be used for an extensive countrywide mandate that includes testing every UK citizen once a week.
Read MoreSiemens Healthineers’ Advia Centaur Interleukin-6 test can be used to determine the risk of mechanical ventilation for hospitalized covid-19 patients.
Read MoreWith support from the CDC, Illumina and Helix have already identified more than 50 cases of the new covid-19 variant in the United States.
Read MoreNIH researchers developed two covid-19 assays to detect the spike protein and receptor binding protein, achieving sensitivity of 100% and specificity of 100% using the Mitra Microsampler from Neoteryx.
Read MoreThrough the agreement, Fulgent will provide covid-19 testing for thousands of students and employees at many K-12 schools in New York City on a daily basis.
Read MoreResearchers from Gadjah Mada University in Indonesia have developed a simple breathalyzer test that they say can electronically “smell’ coronavirus and detect infection in under 2 minutes.
Read MoreFDA issued a safety communication to alert patients and healthcare providers of the risk of false negative covid-19 results with the Curative SARS-Cov-2 test.
Read MoreThe online infographic provides a visualization of data about the coronavirus (covid-19) diagnostic tests authorized by the FDA in 2020.
Read MoreUse of pooled sampling with Enzo’s molecular diagnostic technology can help rapidly expand the number of people tested for covid-19.
Read MoreFDA is resuming its virtual town halls for labs, developers, and manufacturers of covid-19 tests.
Read MoreIn-depth reporting from The Washington Post sheds light on how errors and delays from the CDC delayed pandemic response in the United States.
Read MoreThe easy-to-use, visually read test could expand testing for covid-19 to diverse point-of-care locations.
Read More